Global Vaccine Adjuvants Market By Product Type (Pathogen, Adjuvant Emulsion, And Others), By Route Of Administration (Oral, Intradermal, Subcutaneous), By Disease Type, By Application (Research And Commercial), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2027
- Published date: Sep 2021
- Report ID: 21362
- Number of Pages: 344
- Format:
- keyboard_arrow_up
- 1 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
- 2 Chapter 2
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Product Type
- 2.2.2 Market Snapshot, By Route of Administration
- 2.2.3 Market Snapshot, By Disease Type
- 2.2.4 Market Snapshot, By Application
- 2.2.5 Market Snapshot, By Region
- 2.2.6 Prudour Opportunity Map Analysis
- 2.1 Report Description
- 3 Chapter 3
- 3.0.1 Global Vaccine Adjuvants Market Dynamics
- 3.0.2 Drivers (D)
- 3.0.3 Restraints (R)
- 3.0.4 Opportunities
- 3.0.5 Trends
- 3.0.6 DR Impact Analysis
- 3.0.7 PEST Analysis
- 3.0.8 PORTER’S Five Forces Analysis
- 3.0.9 Value Chain Analysis
- 3.0.10 Regulatory Scenario
- 3.0.11 Pipeline Assessment
- 3.0.12 Epidemiology
- 3.0.13 Reimbursement Scenario
- 3.0.14 Pricing Analysis
- 4 Chapter 4
- 4.0.1 Global Vaccine Adjuvants Market Analysis, by Product Type
- 4.0.2 Overview
- 4.0.3 Segment Trends
- 4.0.4 Market Value (US$ Mn) and Forecast, 2017-2027
- 4.1 Pathogen
- 4.1.1 Overview
- 4.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 4.2 Adjuvant Emulsion
- 4.2.1 Overview
- 4.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 4.3 Particulate
- 4.3.1 Overview
- 4.3.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 4.4 Combination
- 4.4.1 Overview
- 4.4.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 4.5 Others
- 4.5.1 Overview
- 4.5.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 5 Chapter 5
- 5.0.1 Global Vaccine Adjuvants Market Analysis, by Route of Administration
- 5.0.2 Overview
- 5.0.3 Segment Trends
- 5.0.4 Market Value (US$ Mn) and Forecast, 2017-2027
- 5.1 Oral
- 5.1.1 Overview
- 5.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 5.2 Intradermal
- 5.2.1 Overview
- 5.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 5.3 Intranasal
- 5.3.1 Overview
- 5.3.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 5.4 Intramuscular
- 5.4.1 Overview
- 5.4.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 5.5 Subcutaneous
- 5.5.1 Overview
- 5.5.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 6 Chapter 6
- 6.0.1 Global Vaccine Adjuvants Market Analysis, by Disease Type
- 6.0.2 Overview
- 6.0.3 Segment Trends
- 6.0.4 Market Value (US$ Mn) and Forecast, 2017-2027
- 6.1 Infectious Disease
- 6.1.1 Overview
- 6.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 6.2 Cancer
- 6.2.1 Overview
- 6.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 7 Chapter 7
- 7.0.1 Global Vaccine Adjuvants Market Analysis, by Application
- 7.0.2 Overview
- 7.0.3 Segment Trends
- 7.0.4 Market Value (US$ Mn) and Forecast, 2017-2027
- 7.1 Research
- 7.1.1 Overview
- 7.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 7.2 Commercial
- 7.2.1 Overview
- 7.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8 Chapter 8
- 8.0.1 Global Vaccine Adjuvants Market Analysis, by Region
- 8.0.2 Overview
- 8.0.3 Regional Trends
- 8.0.4 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.0.5 Market Attractiveness Index
- 8.1 Global Vaccine Adjuvants Market Analysis, by North America
- 8.1.1 Overview
- 8.1.2 Country Trends
- 8.1.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8.1.4 US
- 8.1.4.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.1.5 Canada
- 8.1.5.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2 Global Vaccine Adjuvants Market Analysis, by Europe
- 8.2.1 Overview
- 8.2.2 Country Trends
- 8.2.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8.2.4 Germany
- 8.2.4.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2.5 UK
- 8.2.5.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2.6 France
- 8.2.6.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2.7 Russia
- 8.2.7.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2.8 Italy
- 8.2.8.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.2.9 Rest of Europe
- 8.2.9.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.3 Global Vaccine Adjuvants Market Analysis, by Asia Pacific
- 8.3.1 Overview
- 8.3.2 Country Trends
- 8.3.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8.3.4 China
- 8.3.4.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.3.5 India
- 8.3.5.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.3.6 Japan
- 8.3.6.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.3.7 Australia
- 8.3.7.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.3.8 Rest of Asia Pacific
- 8.3.8.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.4 Global Vaccine Adjuvants Market Analysis, by Latin America
- 8.4.1 Overview
- 8.4.2 Country Trends
- 8.4.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8.4.4 Brazil
- 8.4.4.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.4.5 Mexico
- 8.4.5.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.4.6 Rest of Latin America
- 8.4.6.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.5 Global Vaccine Adjuvants Market Analysis, by Middle East & Africa
- 8.5.1 Overview
- 8.5.2 Country Trends
- 8.5.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017-2027
- 8.5.4 GCC
- 8.5.4.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.5.5 Israel
- 8.5.5.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.5.6 South Africa
- 8.5.6.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 8.5.7 Rest of Middle East & Africa
- 8.5.7.1 Market Value (US$ Mn) and Forecast, 2017-2027
- 9 Chapter 9
- 9.0.1 Company Share Analysis
- 9.0.2 Company Profiles
- 9.1 Brenntag Biosector A/S
- 9.1.1 Company Overview
- 9.1.2 Product Portfolio
- 9.1.3 Contact Information
- 9.2 CSL Limited
- 9.2.1 Company Overview
- 9.2.2 Product Portfolio
- 9.2.3 Financial Overview
- 9.2.4 Recent Developments
- 9.2.5 SWOT Analysis
- 9.2.6 Contact Information
- 9.3 Air Liquide S.A.
- 9.3.1 Company Overview
- 9.3.2 Product Portfolio
- 9.3.3 Financial Overview
- 9.3.4 Recent Developments
- 9.3.5 SWOT Analysis
- 9.3.6 Contact Information
- 9.4 Agenus, Inc.
- 9.4.1 Company Overview
- 9.4.2 Product Portfolio
- 9.4.3 Recent Developments
- 9.4.4 Contact Information
- 9.5 Novavax, Inc.
- 9.5.1 Company Overview
- 9.5.2 Product Portfolio
- 9.5.3 Financial Overview
- 9.5.4 Recent Developments
- 9.5.5 SWOT Analysis
- 9.5.6 Contact Information
- 9.6 Associated British Foods plc (SPI Pharma, Inc.)
- 9.6.1 Company Overview
- 9.6.2 Product Portfolio
- 9.6.3 Financial Overview
- 9.6.4 SWOT Analysis
- 9.6.5 Contact Information
- 9.7 InvivoGen Inc.
- 9.7.1 Company Overview
- 9.7.2 Product Portfolio
- 9.7.3 Contact Information
- 9.8 Avanti Polar Lipids, Inc.
- 9.8.1 Company Overview
- 9.8.2 Product Portfolio
- 9.8.3 Contact Information
- 9.9 MVP Laboratories, Inc.
- 9.9.1 Company Overview
- 9.9.2 Product Portfolio
- 9.9.3 Contact Information
- 9.10 OZ Biosciences
- 9.10.1 Company Overview
- 9.10.2 Product Portfolio
- 9.10.3 SWOT Analysis
- 9.10.4 Contact Information
- 10 Chapter 10
- 10.0.1 Research Methodology
- 10.0.2 About Us
- 1 Chapter 1
- Brenntag Biosector A/S
- CSL Limited
- Air Liquide S.A.
- Agenus Inc.
- Novavax Inc
- Associated British Foods plc (SPI Pharma Inc)
- InvivoGen Inc.
- Avanti Polar Lipids Inc
- MVP Laboratories Inc.
- OZ Biosciences
- settingsSettings
Our Clients
- 21362
- Sep 2021
-
US $5,999US $2,999
-
US $7,999US $3,499
-
US $12,999US $4,499
✖
Request a Sample Report
We'll get back to you as quickly as possible|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |
